• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

射血分数保留的心力衰竭伴高血压左心室肥厚患者的血液免疫细胞改变

Blood Immune Cell Alterations in Patients with Hypertensive Left Ventricular Hypertrophy and Heart Failure with Preserved Ejection Fraction.

作者信息

Ovchinnikov Artem, Filatova Anastasiya, Potekhina Alexandra, Arefieva Tatiana, Gvozdeva Anna, Ageev Fail, Belyavskiy Evgeny

机构信息

Laboratory of Myocardial Fibrosis and Heart Failure with Preserved Ejection Fraction, Institute of Clinical Cardiology, National Medical Research Center of Cardiology Named after Academician E.I. Chazov, 121552 Moscow, Russia.

Department of Clinical Functional Diagnostics, A.I. Yevdokimov Moscow State University of Medicine and Dentistry, 127473 Moscow, Russia.

出版信息

J Cardiovasc Dev Dis. 2023 Jul 20;10(7):310. doi: 10.3390/jcdd10070310.

DOI:10.3390/jcdd10070310
PMID:37504566
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10380876/
Abstract

(1) Background: Chronic inflammation and fibrosis are key players in cardiac remodeling associated with left ventricular hypertrophy (LVH) and heart failure with a preserved ejection fraction (HFpEF). Monocytes and T-helpers (Th) are involved in both pro-inflammatory and fibrotic processes, while regulatory T-cells (Treg) could be considered to suppress chronic inflammation in the hypertrophied myocardium. We aimed to estimate the relationship between the frequencies of circulating CD4 T-cell and monocyte subpopulations and the variables of left ventricular (LV) diastolic function in patients with LVH depending on the presence of HFpEF. (2) Methods: We enrolled 57 patients with asymptomatic hypertensive LVH ( = 21), or LVH associated with HFpEF ( = 36). A clinical assessment and echocardiographs were analyzed. CD4 Treg, activated Th (Th-act), and monocyte (classical, intermediate, and non-classical) subpopulations were evaluated via direct immunofluorescence and flow cytometry. (3) Results: Patients with HFpEF had a lower Treg/Th-act ratio ( = 0.001). Though asymptomatic patients and patients with HFpEF were comparable in terms of both the total monocyte number and monocyte subsets, there were moderate correlations between intermediate monocyte count and conventional and novel echocardiographic variables of LV diastolic dysfunction in patients with HFpEF. (4) Conclusions: In patients with LVH, the clinical deterioration (transition to HFpEF) and progression of LV diastolic dysfunction are probably associated with T-cell disbalance and an increase in intermediate monocyte counts.

摘要

(1)背景:慢性炎症和纤维化是与左心室肥厚(LVH)及射血分数保留的心力衰竭(HFpEF)相关的心脏重塑的关键因素。单核细胞和辅助性T细胞(Th)参与促炎和纤维化过程,而调节性T细胞(Treg)可被认为能抑制肥厚心肌中的慢性炎症。我们旨在评估根据HFpEF的存在情况,LVH患者循环CD4 T细胞和单核细胞亚群频率与左心室(LV)舒张功能变量之间的关系。(2)方法:我们纳入了57例无症状高血压LVH患者(n = 21)或与HFpEF相关的LVH患者(n = 36)。分析了临床评估和超声心动图。通过直接免疫荧光和流式细胞术评估CD4 Treg、活化的Th(Th-act)和单核细胞(经典、中间和非经典)亚群。(3)结果:HFpEF患者的Treg/Th-act比值较低(P = 0.001)。尽管无症状患者和HFpEF患者在总单核细胞数量和单核细胞亚群方面具有可比性,但在HFpEF患者中,中间单核细胞计数与LV舒张功能障碍的传统和新型超声心动图变量之间存在中度相关性。(4)结论:在LVH患者中,临床恶化(转变为HFpEF)和LV舒张功能障碍的进展可能与T细胞失衡和中间单核细胞计数增加有关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a06/10380876/2ddd0802875c/jcdd-10-00310-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a06/10380876/0eb846d976d0/jcdd-10-00310-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a06/10380876/5a21ad478423/jcdd-10-00310-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a06/10380876/560a136b8953/jcdd-10-00310-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a06/10380876/26eae8e367fb/jcdd-10-00310-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a06/10380876/74f7d93b0a1b/jcdd-10-00310-g005a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a06/10380876/2ddd0802875c/jcdd-10-00310-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a06/10380876/0eb846d976d0/jcdd-10-00310-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a06/10380876/5a21ad478423/jcdd-10-00310-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a06/10380876/560a136b8953/jcdd-10-00310-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a06/10380876/26eae8e367fb/jcdd-10-00310-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a06/10380876/74f7d93b0a1b/jcdd-10-00310-g005a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a06/10380876/2ddd0802875c/jcdd-10-00310-g006.jpg

相似文献

1
Blood Immune Cell Alterations in Patients with Hypertensive Left Ventricular Hypertrophy and Heart Failure with Preserved Ejection Fraction.射血分数保留的心力衰竭伴高血压左心室肥厚患者的血液免疫细胞改变
J Cardiovasc Dev Dis. 2023 Jul 20;10(7):310. doi: 10.3390/jcdd10070310.
2
Impaired systolic function by strain imaging in heart failure with preserved ejection fraction.应变成像技术评估射血分数保留心力衰竭患者的收缩功能障碍。
J Am Coll Cardiol. 2014 Feb 11;63(5):447-56. doi: 10.1016/j.jacc.2013.09.052. Epub 2013 Oct 30.
3
Asymptomatic Left Ventricular Hypertrophy Is a Potent Risk Factor for the Development of HFpEF but Not HFrEF: Results of a Retrospective Cohort Study.无症状性左心室肥厚是射血分数保留的心力衰竭(HFpEF)而非射血分数降低的心力衰竭(HFrEF)发生发展的有力危险因素:一项回顾性队列研究结果
J Clin Med. 2022 Jul 4;11(13):3885. doi: 10.3390/jcm11133885.
4
Association between long-term prescription of febuxostat and the progression of heart failure with preserved ejection fraction in patients with hypertension and asymptomatic hyperuricemia.非布司他长期处方与高血压合并无症状高尿酸血症患者射血分数保留的心力衰竭进展之间的关联
Heart Vessels. 2020 Oct;35(10):1446-1453. doi: 10.1007/s00380-020-01619-8. Epub 2020 May 19.
5
Myocardial hypertrophy and its role in heart failure with preserved ejection fraction.心肌肥厚及其在射血分数保留的心力衰竭中的作用。
J Appl Physiol (1985). 2015 Nov 15;119(10):1233-42. doi: 10.1152/japplphysiol.00374.2015. Epub 2015 Jul 16.
6
Increased Myocardial Stiffness in Patients With High-Risk Left Ventricular Hypertrophy: The Hallmark of Stage-B Heart Failure With Preserved Ejection Fraction.高危左心室肥厚患者心肌僵硬度增加:射血分数保留的心力衰竭 B 期的标志。
Circulation. 2020 Jan 14;141(2):115-123. doi: 10.1161/CIRCULATIONAHA.119.040332. Epub 2019 Dec 23.
7
Cardiovascular features of heart failure with preserved ejection fraction versus nonfailing hypertensive left ventricular hypertrophy in the urban Baltimore community: the role of atrial remodeling/dysfunction.巴尔的摩市区社区射血分数保留的心力衰竭与非衰竭高血压左心室肥厚的心血管特征:心房重塑/功能障碍的作用
J Am Coll Cardiol. 2007 Jan 16;49(2):198-207. doi: 10.1016/j.jacc.2006.08.050. Epub 2006 Dec 29.
8
A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation.一种新型射血分数保留心力衰竭模式:合并症通过冠状动脉微血管内皮炎症导致心肌功能障碍和重构。
J Am Coll Cardiol. 2013 Jul 23;62(4):263-71. doi: 10.1016/j.jacc.2013.02.092. Epub 2013 May 15.
9
Association between long-term prescription of aldosterone antagonist and the progression of heart failure with preserved ejection fraction in hypertensive patients.醛固酮拮抗剂长期处方与高血压患者射血分数保留的心力衰竭进展之间的关联。
Int J Cardiol. 2016 Oct 1;220:56-60. doi: 10.1016/j.ijcard.2016.06.190. Epub 2016 Jun 25.
10
Exaggerated inflammation and monocytosis associate with diastolic dysfunction in heart failure with preserved ejection fraction: evidence of M2 macrophage activation in disease pathogenesis.射血分数保留的心力衰竭中,过度炎症反应和单核细胞增多与舒张功能障碍相关:疾病发病机制中M2巨噬细胞激活的证据。
J Card Fail. 2015 Feb;21(2):167-77. doi: 10.1016/j.cardfail.2014.11.004. Epub 2014 Nov 18.

引用本文的文献

1
Cardiometabolic Phenotype in HFpEF: Insights from Murine Models.射血分数保留的心力衰竭中的心脏代谢表型:来自小鼠模型的见解
Biomedicines. 2025 Mar 18;13(3):744. doi: 10.3390/biomedicines13030744.
2
Comprehensive analysis of disulfidptosis-related genes and the immune microenvironment in heart failure.心力衰竭中与二硫键介导的细胞焦亡相关基因及免疫微环境的综合分析
Front Cell Dev Biol. 2025 Jan 17;12:1516898. doi: 10.3389/fcell.2024.1516898. eCollection 2024.
3
Association of systemic inflammatory markers with clinical adverse prognosis and outcomes in HFpEF: a systematic review and meta-analysis of cohort studies.

本文引用的文献

1
Fibroblast and Immune Cell Cross-Talk in Cardiac Fibrosis.成纤维细胞与免疫细胞在心脏纤维化中的相互作用。
Curr Cardiol Rep. 2023 Jun;25(6):485-493. doi: 10.1007/s11886-023-01877-8. Epub 2023 Apr 19.
2
Hypertensive Heart Disease: A Narrative Review Series-Part 1: Pathophysiology and Microstructural Changes.高血压性心脏病:叙述性综述系列 - 第1部分:病理生理学和微观结构变化
J Clin Med. 2023 Mar 30;12(7):2606. doi: 10.3390/jcm12072606.
3
Immune Profiling Reveals Decreases in Circulating Regulatory and Exhausted T Cells in Human Hypertension.
射血分数保留的心力衰竭中全身炎症标志物与临床不良预后及结局的关联:队列研究的系统评价和荟萃分析
Front Cardiovasc Med. 2024 Sep 30;11:1461073. doi: 10.3389/fcvm.2024.1461073. eCollection 2024.
4
Role of Treg cell subsets in cardiovascular disease pathogenesis and potential therapeutic targets.调节性 T 细胞亚群在心血管疾病发病机制中的作用及潜在治疗靶点。
Front Immunol. 2024 Mar 15;15:1331609. doi: 10.3389/fimmu.2024.1331609. eCollection 2024.
免疫谱分析揭示人类高血压患者循环调节性T细胞和耗竭性T细胞减少。
JACC Basic Transl Sci. 2023 Jan 4;8(3):319-336. doi: 10.1016/j.jacbts.2022.09.007. eCollection 2023 Mar.
4
Targeting regulatory T cells for cardiovascular diseases.靶向调节性 T 细胞治疗心血管疾病。
Front Immunol. 2023 Feb 23;14:1126761. doi: 10.3389/fimmu.2023.1126761. eCollection 2023.
5
Neutrophils and Circulating Inflammatory Biomarkers in Diabetes Mellitus and Heart Failure With Preserved Ejection Fraction.中性粒细胞和循环炎症生物标志物在糖尿病和射血分数保留的心力衰竭中的作用。
Am J Cardiol. 2022 Sep 1;178:80-88. doi: 10.1016/j.amjcard.2022.05.026. Epub 2022 Jul 8.
6
Inflammation in obesity, diabetes, and related disorders.肥胖、糖尿病及相关紊乱中的炎症。
Immunity. 2022 Jan 11;55(1):31-55. doi: 10.1016/j.immuni.2021.12.013.
7
Fibrosis of the diabetic heart: Clinical significance, molecular mechanisms, and therapeutic opportunities.糖尿病性心肌病的纤维化:临床意义、分子机制及治疗前景
Adv Drug Deliv Rev. 2021 Sep;176:113904. doi: 10.1016/j.addr.2021.113904. Epub 2021 Jul 29.
8
Immuno-metabolic interfaces in cardiac disease and failure.免疫代谢在心脏疾病和衰竭中的相互作用。
Cardiovasc Res. 2022 Jan 7;118(1):37-52. doi: 10.1093/cvr/cvab036.
9
SPARC production by bone marrow-derived cells contributes to myocardial fibrosis in pressure overload.骨髓来源细胞产生的 SPARC 有助于压力超负荷引起的心肌纤维化。
Am J Physiol Heart Circ Physiol. 2021 Feb 1;320(2):H604-H612. doi: 10.1152/ajpheart.00552.2020. Epub 2020 Dec 11.
10
The Molecular and Cellular Mechanisms Associated with a Microvascular Inflammation in the Pathogenesis of Heart Failure with Preserved Ejection Fraction.射血分数保留的心力衰竭发病机制中与微血管炎症相关的分子和细胞机制
Acta Naturae. 2020 Apr-Jun;12(2):40-51. doi: 10.32607/actanaturae.10990.